{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:37:00Z","timestamp":1784191020559,"version":"3.55.0"},"reference-count":35,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,3,1]]},"abstract":"<jats:p>OBJECTIVES. Influenza is a leading cause of illness among children. Studies rarely have measured influenza vaccine effectiveness among young children, particularly when antigenic match between vaccine and circulating viruses is suboptimal. We assessed vaccine effectiveness against medically attended, laboratory-confirmed influenza for children who were aged 6 to 59 months during the 2003\u20132004 influenza season.<\/jats:p>\n               <jats:p>METHODS. In a case-control study that was conducted in a single pediatric practice, case patients who were aged 6 to 59 months and had laboratory-confirmed influenza were age matched 1:2 to eligible control subjects. Vaccination status was ascertained as of the date of the case patient\u2019s symptom onset. Conditional logistic regression was used to calculate vaccine effectiveness, adjusting for underlying medical conditions and health care usage.<\/jats:p>\n               <jats:p>RESULTS. We identified 290 influenza case patients who were seen for medical care from November 1, 2003, to January 31, 2004. Vaccine effectiveness among fully vaccinated children, compared with unvaccinated children, was 49%. Partially vaccinated children who were aged 6 to 23 months had no significant reduction in influenza (vaccine effectiveness: \u221270%), but partially vaccinated children who were aged 24 to 59 months had a significant (65%) reduction in influenza, compared with unvaccinated children.<\/jats:p>\n               <jats:p>CONCLUSIONS. Full vaccination provided measurable protection against laboratory-confirmed influenza among children who were aged 6 to 59 months during a season with suboptimal vaccine match. No vaccine effectiveness was identified with partial vaccination among children who were aged 6 to 23 months, affirming that children need to be fully vaccinated to obtain protective effects. These results strengthen the evidence of the vaccine\u2019s ability to reduce substantially the burden of disease in this age group.<\/jats:p>","DOI":"10.1542\/peds.2006-1878","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T05:39:09Z","timestamp":1172813949000},"page":"e587-e595","source":"Crossref","is-referenced-by-count":93,"title":["Vaccine Effectiveness Against Medically Attended, Laboratory-Confirmed Influenza Among Children Aged 6 to 59 Months, 2003\u20132004"],"prefix":"10.1542","volume":"119","author":[{"given":"Carrie M.","family":"Shuler","sequence":"first","affiliation":[{"name":"Epidemic Intelligence Service"},{"name":"Notifiable Diseases Section, Division of Public Health, Georgia Department of Human Resources, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Iwamoto","sequence":"additional","affiliation":[{"name":"Epidemic Intelligence Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn Buxton","family":"Bridges","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Marin","sequence":"additional","affiliation":[{"name":"Epidemic Intelligence Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Neeman","sequence":"additional","affiliation":[{"name":"Notifiable Diseases Section, Division of Public Health, Georgia Department of Human Resources, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gargiullo","sequence":"additional","affiliation":[{"name":"Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrace A.","family":"Yoder","sequence":"additional","affiliation":[{"name":"Children\u2019s Medical Group, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L.","family":"Keyserling","sequence":"additional","affiliation":[{"name":"School of Medicine, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline D.","family":"Terebuh","sequence":"additional","affiliation":[{"name":"Notifiable Diseases Section, Division of Public Health, Georgia Department of Human Resources, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2007,3,1]]},"reference":[{"key":"2021120901540440500_R1","doi-asserted-by":"crossref","unstructured":"Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med.\u20082006;355:31\u201340","DOI":"10.1056\/NEJMoa054869"},{"key":"2021120901540440500_R2","doi-asserted-by":"crossref","unstructured":"Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalization, outpatient visits, and courses of antibiotics in children. N Engl J Med.\u20082000;342:225\u2013231","DOI":"10.1056\/NEJM200001273420401"},{"key":"2021120901540440500_R3","doi-asserted-by":"crossref","unstructured":"O\u2019Brien MA, Uyeki TM, Shay DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics.\u20082004;113:585\u2013593","DOI":"10.1542\/peds.113.3.585"},{"key":"2021120901540440500_R4","doi-asserted-by":"crossref","unstructured":"Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA.\u20082003;289:179\u2013186","DOI":"10.1001\/jama.289.2.179"},{"key":"2021120901540440500_R5","doi-asserted-by":"crossref","unstructured":"Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis.\u20082002;185:147\u2013152","DOI":"10.1086\/338363"},{"key":"2021120901540440500_R6","doi-asserted-by":"crossref","unstructured":"Committee on Infectious Diseases. Reduction of the influenza burden in children. Pediatrics.\u20082002;110:1246\u20131252","DOI":"10.1542\/peds.110.6.1246"},{"key":"2021120901540440500_R7","doi-asserted-by":"crossref","unstructured":"Iwane MK, Edwards KM, Szilagyi PG, et al, New Vaccine Surveillance Network. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics.\u20082004;113:1758\u20131764","DOI":"10.1542\/peds.113.6.1758"},{"key":"2021120901540440500_R8","doi-asserted-by":"crossref","unstructured":"Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med.\u20082000;342:232\u2013239","DOI":"10.1056\/NEJM200001273420402"},{"key":"2021120901540440500_R9","unstructured":"Advisory Committee on Immunization Practices; Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Morb Mortal Wkly Rep. 2006;55:800]. MMWR Recomm Rep.\u20082006;55:1\u201342"},{"key":"2021120901540440500_R10","doi-asserted-by":"crossref","unstructured":"Humiston SG, Szilagyi PG, Iwane MK, et al. The feasibility of universal influenza vaccination for infants and toddlers. Arch Pediatr Adolesc Med.\u20082004;158:867\u2013874","DOI":"10.1001\/archpedi.158.9.867"},{"key":"2021120901540440500_R11","doi-asserted-by":"crossref","unstructured":"Szilagyi PG, Iwane MK, Schaffer S, et al. Potential burden of universal influenza vaccination of young children on visits to primary care practices. Pediatrics.\u20082003;112:821\u2013828","DOI":"10.1542\/peds.112.4.821"},{"key":"2021120901540440500_R12","doi-asserted-by":"crossref","unstructured":"Heikkinen TH, Ruuskanen L, Waris M, Ziegler T, Arola M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child.\u20081991;145:445\u2013448","DOI":"10.1001\/archpedi.1991.02160040103017"},{"key":"2021120901540440500_R13","doi-asserted-by":"crossref","unstructured":"Ritzwoller DP, Bridges CB, Shetterly S, Yamasaki K, Kolczak M, France EK. Effectiveness of the 2003\u20132004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics.\u20082005;116:153\u2013159","DOI":"10.1542\/peds.2005-0049"},{"key":"2021120901540440500_R14","doi-asserted-by":"crossref","unstructured":"Hoberman A, Greenberg D, Paradise JL, et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children. JAMA.\u20082003;290:1608\u20131616","DOI":"10.1001\/jama.290.12.1608"},{"key":"2021120901540440500_R15","doi-asserted-by":"crossref","unstructured":"Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A, Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet.\u20082005;365:773\u2013780","DOI":"10.1016\/S0140-6736(05)17984-7"},{"key":"2021120901540440500_R16","doi-asserted-by":"crossref","unstructured":"Gonzalez M, Pirez MC, Ward E, Dibarboure H, Garcia A, Picolet H. Safety and immunogenicity of a paediatric presentation of an influenza vaccine. Arch Dis Child.\u20082000;83:488\u2013491","DOI":"10.1136\/adc.83.6.488"},{"key":"2021120901540440500_R17","doi-asserted-by":"crossref","unstructured":"Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J.\u20082001;20:733\u2013740","DOI":"10.1097\/00006454-200108000-00004"},{"key":"2021120901540440500_R18","unstructured":"Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA; Advisory Committee on Immunization Practices. Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP) [published correction appears in MMWR Morb Mortal Wkly Rep. 2003;52:526]. MMWR Recomm Rep.\u20082003;52:1\u201334"},{"key":"2021120901540440500_R19","unstructured":"Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP) [published correction appears in MMWR Recomm Rep. 2004;53:743]. MMWR Recomm Rep.\u20082004;53:1\u201340"},{"key":"2021120901540440500_R20","unstructured":"Centers for Disease Control and Prevention. Update: influenza activity\u2014United States, 2003\u20132004 season. MMWR Morb Mortal Wkly Rep.\u20082003;52:1197\u20131202"},{"key":"2021120901540440500_R21","unstructured":"Han A, Arnold K, Terebuh P. Influenza. Georgia Epidemiol Rep.\u20082004;20:1\u20133"},{"key":"2021120901540440500_R22","doi-asserted-by":"crossref","unstructured":"Bhat N, Wright JG, Broder KR et al. Influenza-associated deaths among children in the United States, 2003\u20132004. N Engl J Med.\u20082005;353:2559\u20132567","DOI":"10.1056\/NEJMoa051721"},{"key":"2021120901540440500_R23","doi-asserted-by":"crossref","unstructured":"Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Epidemiol Rev.\u20081988;10:212\u2013241","DOI":"10.1093\/oxfordjournals.epirev.a036023"},{"key":"2021120901540440500_R24","unstructured":"Quidel Corporation. QuickVue Fact Sheet. Available at: www.quidel.com\/products. Accessed June 19, 2006"},{"key":"2021120901540440500_R25","doi-asserted-by":"crossref","unstructured":"Robins JM, Prentice RL, Blevins D. Designs for synthetic case-control studies in open cohorts. Biometrics.\u20081989;45:1103\u20131116","DOI":"10.2307\/2531763"},{"key":"2021120901540440500_R26","doi-asserted-by":"crossref","unstructured":"Comstock GW. Evaluating vaccination effectiveness and vaccine efficacy by means of case-control studies. Epidemiol Rev.\u20081994;16:77\u201389","DOI":"10.1093\/oxfordjournals.epirev.a036147"},{"key":"2021120901540440500_R27","doi-asserted-by":"crossref","unstructured":"Prentice RL. On the design of synthetic case-control studies. Biometrics.\u20081986;42:301\u2013310","DOI":"10.2307\/2531051"},{"key":"2021120901540440500_R28","doi-asserted-by":"crossref","unstructured":"Hurwitz ES, Haber M, Chang A, et al. Studies of the 1996\u20131997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis.\u20082000;182:1218\u20131221","DOI":"10.1086\/315820"},{"key":"2021120901540440500_R29","doi-asserted-by":"crossref","unstructured":"Kumagai T, Nagai K, Okui T, et al. Poor immune responses to influenza vaccination in infants. Vaccine.\u20082004;22:3404\u20133410","DOI":"10.1016\/j.vaccine.2004.02.030"},{"key":"2021120901540440500_R30","doi-asserted-by":"crossref","unstructured":"Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Pediatrics.\u20082005;115:1039\u20131047","DOI":"10.1542\/peds.2004-2373"},{"key":"2021120901540440500_R31","doi-asserted-by":"crossref","unstructured":"Hak E, Verheij TJ, Grobbee De, Nichol KL, Hoes AW. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health.\u20082002;56:951\u2013955","DOI":"10.1136\/jech.56.12.951"},{"key":"2021120901540440500_R32","doi-asserted-by":"crossref","unstructured":"Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J.\u20082004;23:189\u2013200","DOI":"10.1097\/01.inf.0000116292.46143.d6"},{"key":"2021120901540440500_R33","unstructured":"Centers for Disease Control and Prevention. Childhood influenza vaccination coverage\u2014United States, 2003\u20132004 influenza season. MMWR Morb Mortal Wkly Rep.\u20082006;55:100\u2013103"},{"key":"2021120901540440500_R34","doi-asserted-by":"crossref","unstructured":"Hak E, Hoes AR, Nordin J, Nichol KL. Benefits of influenza vaccine in U.S. elderly: appreciating issues of confounding bias and precision. Int J Epidemiol.\u20082006;35:800\u2013802; author reply 799\u2013800","DOI":"10.1093\/ije\/dyl068"},{"key":"2021120901540440500_R35","doi-asserted-by":"crossref","unstructured":"Neuzil KM, Jackson LA, Nelson J, et al. Immunogenicity and reactogenicity of one versus two doses of trivalent inactivated influenza vaccine in vaccine-nai\u0308ve 5\u20138-year-old children. J Infect Disease.\u20082006;194:1032\u20131039","DOI":"10.1086\/507309"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/119\/3\/e587\/1112729\/zpe0030700e587.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/119\/3\/e587\/1112729\/zpe0030700e587.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T08:13:19Z","timestamp":1639037599000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/119\/3\/e587\/70437\/Vaccine-Effectiveness-Against-Medically-Attended"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,1]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2007,3,1]]},"published-print":{"date-parts":[[2007,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-1878","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,1]]}}}